Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022
These data provide invaluable insights into the latest epidemiology of female breast cancer in China and highlight the urgency for disease prevention and control strategy formulation.
Authors
- Shaoyuan Lei
- Wenqiang Wei
- Xiaolong Feng (ORCID: https://orcid.org/0000-0003-4942-9927)
- Yifei Yao (ORCID: https://orcid.org/0000-0003-0660-4158)
- Shaoming Wang (ORCID: https://orcid.org/0000-0002-3980-1919)
- Rongshou Zheng (ORCID: https://orcid.org/0000-0003-4295-3398)
- Bingfeng Han (ORCID: https://orcid.org/0000-0002-6807-7026)
- Li Li (ORCID: https://orcid.org/0000-0002-4824-7155)
- Bailin Zhang (ORCID: https://orcid.org/0000-0003-2759-7727)
- Jie He (ORCID: https://orcid.org/0000-0002-0285-5403)
- Xin Liang (ORCID: https://orcid.org/0000-0001-8798-5989)
- Ru Chen (ORCID: https://orcid.org/0009-0004-7315-8607)
- Kexin Sun
- Siwei Zhang (ORCID: https://orcid.org/0000-0002-7878-9940)
- Hongmei Zeng
- Peiqing Ma
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1097/cm9.0000000000003278
- Citations
- 58
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 16.39